Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$18.54 - $35.74 $10.1 Million - $19.5 Million
-545,101 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$19.79 - $26.99 $6.67 Million - $9.09 Million
-336,800 Reduced 38.19%
545,101 $10.8 Million
Q1 2021

May 17, 2021

SELL
$18.57 - $25.68 $10.3 Million - $14.2 Million
-554,091 Reduced 38.59%
881,901 $20.5 Million
Q4 2020

Feb 16, 2021

SELL
$15.26 - $28.61 $3.61 Million - $6.76 Million
-236,300 Reduced 14.13%
1,435,992 $29.8 Million
Q3 2020

Nov 13, 2020

BUY
$20.58 - $28.96 $1.34 Million - $1.88 Million
65,000 Added 4.04%
1,672,292 $36.2 Million
Q2 2020

Aug 13, 2020

SELL
$11.15 - $24.64 $6.36 Million - $14 Million
-570,000 Reduced 26.18%
1,607,292 $37.9 Million
Q1 2020

May 14, 2020

SELL
$8.75 - $16.3 $1.94 Million - $3.61 Million
-221,678 Reduced 9.24%
2,177,292 $25.7 Million
Q4 2019

Feb 14, 2020

BUY
$7.95 - $11.84 $3.98 Million - $5.92 Million
500,000 Added 26.33%
2,398,970 $25.5 Million
Q2 2019

Aug 13, 2019

BUY
$7.95 - $11.25 $1.4 Million - $1.98 Million
175,800 Added 10.2%
1,898,970 $21.4 Million
Q1 2019

May 14, 2019

BUY
$5.95 - $10.19 $9.21 Million - $15.8 Million
1,548,022 Added 883.84%
1,723,170 $13.9 Million
Q4 2018

Feb 13, 2019

BUY
$5.91 - $9.29 $1.04 Million - $1.63 Million
175,148 New
175,148 $1.11 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.85B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.